Table 2.
[Quin] | τ (min) |
|
---|---|---|
0 nm | 100 nm | |
37a | 7.00 ± 1.23 (3) | n/a |
37a + D2R | 11.1 ± 1.43 (5) | 6.60 ± 0.22 (3) |
37b | 11.6 ± 3.53 (3) | n/a |
37b + D2R | 29.0 ± 4.89 (4) | 6.90 ± 0.36 (3) |
37a L/A | 13.8 ± 1.85 (4) | n/a |
37a L/A + D2R | 27.3 ± 4.43 (3) | 18.6 ± 1.62 (3) |
37a Y/A | 21.1 ± 3.53 (4) | n/a |
37a Y/A + D2R | 12.6 ± 2.20 (3) | 7.28 ± 0.90 (3) |
The endocytosis time constants (τ) for CaV2.2 splice variants 37a and 37b and the 37a mutants, either alone or in combination with the D2R, are shown. When the D2R was included, experiments were performed in the absence (middle) or presence (right) of the D2R agonist Quin (100 nm). Number of different separate experiments are given in parentheses, with at least 20 cells per time point for each experiment.